Medindia » Press Release » AcelRx Pharmaceuticals Scheduled to Present at the JP Morgan Healthcare Conference in San Francisco on January 15, 2009
Latest Headlines
WHO Says Access to Swine Flu Vaccine a 'critical Question' (8 hrs ago)
Memory Decline in Alzheimer's Mice Set Right by Human Blood Stem Cell Growth Factor (8 hrs ago)
Scientists Identify Why H1N1 Flu Spreads from Person to Person Less Effectively Than Other Flu Viruses (8 hrs ago)
PET can Measure Effectiveness of Novel Breast Cancer Treatment, Study Says (8 hrs ago)
Supply of Additional Private Services on the Rise (8 hrs ago)
Increased Research Output Seen in Developing Countries (8 hrs ago)
Call for Public Debates on Future Uses of Stem Cells (8 hrs ago)
All Latest News
News - Quick Links
News Central
Latest Health News
News Category
Popular News
Health News and Press Release
Special Reports
Health Watch
Health In Focus
Breaking Health News
Celebrating Life
Medindia - Exclusive
India Special
Lifestyle and Wellness
Popular News Topics
Health News and Press Release   
Posted online: 23 Dec 2008
Font Size

AcelRx Pharmaceuticals Scheduled to Present at the JP Morgan Healthcare Conference in San Francisco on January 15, 2009

Title: AcelRx Pharmaceuticals Scheduled to Present at the JP Morgan Healthcare Conference in San Francisco on January 15, 2009
Description : AcelRx Pharmaceuticals, Inc., an emerging specialty pharmaceutical company focused on the treatment of intermittent and acute conditions, with an initial emphasis on pain management,
Keywords : CA, AcelRx, conf

REDWOOD CITY, Calif., Dec. 23 AcelRx Pharmaceuticals, Inc., an emerging specialty pharmaceutical company focused on the treatment of intermittent and acute conditions, with an initial emphasis on pain management, announced that it will present at JP Morgan's 27th Annual Healthcare Conference, to be held on Thursday, January 15th, 2009 at the Westin St. Francis Hotel in San Francisco. The AcelRx Pharmaceuticals, Inc., presentation is scheduled to begin at 11:00 a.m. Pacific Standard Time. AcelRx Pharmaceuticals, Inc., will make a presentation on the Company, including recent positive Phase 2 clinical trial results.



SOURCE AcelRx Pharmaceuticals, Inc.

Source :PR Newswire

 Press Release Links
Submit Health News and Press Release
Top 10 Rules for a successful submission
Writing a Press Release
View Latest Press Releases
Why submit a health related Press release to Medindia
Medindia's Reach
   Post Your Comments  
Be the first to comment
* Your comment can be maximum of 2500 characters

 News Archive
 Search by Keyword


Web Medindia  Advanced Search
Feedback
Last Updated - - Designed & Content Managed by Medindia Health Network Pvt Ltd. Hosted & Technical Support by FrontPoint Systems
DisclaimerThe contents of this site are for informational purposes only. Always seek the advice of a qualified physician for any doubts.
To Read full Disclaimer Click Here!
Best viewed with resolution 1024x768 px.
Advertise with us |  Medindia Copyright |  Privacy Policy |  © All Rights Reserved 1997 - 2009